Bristol-Myers Squibb 2012 Annual Report Bristol-Myers Squibb Leadership BoARD of DiRECToRS James M. Cornelius Chairman, Bristol-Myers Squibb Lamberto Andreotti Chief Executive Officer,  Bristol-Myers Squibb (d) Lewis B. Campbell Executive Chairman and  Chief Executive Officer, Navistar International Corporation (b,c) Laurie H. Glimcher, M.D.  Stephen and Suzanne Weiss Dean,  Weill Cornell Medical College, and Cornell University Provost for Medical Affairs (a,d) Michael Grobstein Retired Vice Chairman,  Ernst & Young LLP (a,c) Alan J. Lacy Senior Advisor, Oak Hill Capital Partners, L.P. (a,b) Vicki L. Sato, Ph.D. Professor of Management Practice, Harvard Business School, and Professor of the Practice of Molecular and Cell Biology, Harvard University (c,d) Elliott Sigal, M.D., Ph.D.  Executive Vice President, Chief Scientific Officer and President, Research and Development, Bristol-Myers Squibb (d) Gerald L. Storch Chairman and Chief Executive Officer, Toys“R”Us, Inc. (a,c) Togo D. West, Jr. Chairman, TLI Leadership Group and Noblis, Inc. (b,c) R. Sanders Williams, M.D. President and Robert W. and Linda L. Mahley Distinguished Professor, The J. David Gladstone Institutes, and Professor of Medicine, University of California, San Francisco (d) 80 (a) Audit Committee  (b) Committee on Directors and Corporate Governance  (c) Compensation and Management Development Committee (d) Science and Technology Committee